Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 57

1.

Prostaglandin E2 produced following infection with Theiler's virus promotes the pathogenesis of demyelinating disease.

Kim SJ, Jin YH, Kim BS.

PLoS One. 2017 Apr 26;12(4):e0176406. doi: 10.1371/journal.pone.0176406. eCollection 2017.

2.

Variation within MBP gene predicts disease course in multiple sclerosis.

Zhou Y, Simpson S Jr, Charlesworth JC, van der Mei I, Lucas RM, Ponsonby AL; AUSLONG Investigators Group, Taylor BV.

Brain Behav. 2017 Mar 9;7(4):e00670. doi: 10.1002/brb3.670. eCollection 2017 Apr.

3.

Theiler's murine encephalomyelitis virus infection of SJL/J and C57BL/6J mice: Models for multiple sclerosis and epilepsy.

DePaula-Silva AB, Hanak TJ, Libbey JE, Fujinami RS.

J Neuroimmunol. 2017 Jul 15;308:30-42. doi: 10.1016/j.jneuroim.2017.02.012. Epub 2017 Feb 12. Review.

PMID:
28237622
4.

Brain microbiota disruption within inflammatory demyelinating lesions in multiple sclerosis.

Branton WG, Lu JQ, Surette MG, Holt RA, Lind J, Laman JD, Power C.

Sci Rep. 2016 Nov 28;6:37344. doi: 10.1038/srep37344.

5.

Risk factors associated with the onset of relapsing-remitting and primary progressive multiple sclerosis: a systematic review.

McKay KA, Kwan V, Duggan T, Tremlett H.

Biomed Res Int. 2015;2015:817238. doi: 10.1155/2015/817238. Epub 2015 Jan 31. Review.

6.

Immune response to HHV-6 and implications for immunotherapy.

Becerra A, Gibson L, Stern LJ, Calvo-Calle JM.

Curr Opin Virol. 2014 Dec;9:154-61. doi: 10.1016/j.coviro.2014.10.001. Epub 2014 Oct 27. Review.

7.

The development of new therapies for human herpesvirus 6.

Prichard MN, Whitley RJ.

Curr Opin Virol. 2014 Dec;9:148-53. doi: 10.1016/j.coviro.2014.09.019. Epub 2014 Oct 22. Review.

8.

Evidence linking HHV-6 with multiple sclerosis: an update.

Leibovitch EC, Jacobson S.

Curr Opin Virol. 2014 Dec;9:127-33. doi: 10.1016/j.coviro.2014.09.016. Epub 2014 Oct 17. Review.

9.

Recent developments in animal models for human herpesvirus 6A and 6B.

Horvat B, Berges BK, Lusso P.

Curr Opin Virol. 2014 Dec;9:97-103. doi: 10.1016/j.coviro.2014.09.012. Epub 2014 Oct 14. Review.

10.

Anti-human herpesvirus 6A/B IgG correlates with relapses and progression in multiple sclerosis.

Ortega-Madueño I, Garcia-Montojo M, Dominguez-Mozo MI, Garcia-Martinez A, Arias-Leal AM, Casanova I, Arroyo R, Alvarez-Lafuente R.

PLoS One. 2014 Aug 11;9(8):e104836. doi: 10.1371/journal.pone.0104836. eCollection 2014.

11.

Coinfection of human herpesviruses 6A (HHV-6A) and HHV-6B as demonstrated by novel digital droplet PCR assay.

Leibovitch EC, Brunetto GS, Caruso B, Fenton K, Ohayon J, Reich DS, Jacobson S.

PLoS One. 2014 Mar 24;9(3):e92328. doi: 10.1371/journal.pone.0092328. eCollection 2014.

12.

Human herpesvirus 6A infection in CD46 transgenic mice: viral persistence in the brain and increased production of proinflammatory chemokines via Toll-like receptor 9.

Reynaud JM, Jégou JF, Welsch JC, Horvat B.

J Virol. 2014 May;88(10):5421-36. doi: 10.1128/JVI.03763-13. Epub 2014 Feb 26.

13.

Possible role of human herpesvirus 6 as a trigger of autoimmune disease.

Broccolo F, Fusetti L, Ceccherini-Nelli L.

ScientificWorldJournal. 2013 Oct 24;2013:867389. doi: 10.1155/2013/867389. eCollection 2013. Review.

14.
15.

Development of virus-specific CD4+ and CD8+ regulatory T cells induced by human herpesvirus 6 infection.

Wang F, Chi J, Peng G, Zhou F, Wang J, Li L, Feng D, Xie F, Gu B, Qin J, Chen Y, Yao K.

J Virol. 2014 Jan;88(2):1011-24. doi: 10.1128/JVI.02586-13. Epub 2013 Nov 6.

16.

Classification of HHV-6A and HHV-6B as distinct viruses.

Ablashi D, Agut H, Alvarez-Lafuente R, Clark DA, Dewhurst S, DiLuca D, Flamand L, Frenkel N, Gallo R, Gompels UA, Höllsberg P, Jacobson S, Luppi M, Lusso P, Malnati M, Medveczky P, Mori Y, Pellett PE, Pritchett JC, Yamanishi K, Yoshikawa T.

Arch Virol. 2014 May;159(5):863-70. doi: 10.1007/s00705-013-1902-5. Epub 2013 Nov 6. Review.

17.

Immunomodulation and immunosuppression by human herpesvirus 6A and 6B.

Dagna L, Pritchett JC, Lusso P.

Future Virol. 2013 Mar;8(3):273-287.

18.

Human herpesvirus 6A partially suppresses functional properties of DC without viral replication.

Gustafsson RK, Engdahl EE, Hammarfjord O, Adikari SB, Lourda M, Klingström J, Svensson M, Fogdell-Hahn A.

PLoS One. 2013;8(3):e58122. doi: 10.1371/journal.pone.0058122. Epub 2013 Mar 5.

19.

Novel marmoset (Callithrix jacchus) model of human Herpesvirus 6A and 6B infections: immunologic, virologic and radiologic characterization.

Leibovitch E, Wohler JE, Cummings Macri SM, Motanic K, Harberts E, Gaitán MI, Maggi P, Ellis M, Westmoreland S, Silva A, Reich DS, Jacobson S.

PLoS Pathog. 2013 Jan;9(1):e1003138. doi: 10.1371/journal.ppat.1003138. Epub 2013 Jan 31.

20.

No serological evidence for a role of HHV-6 infection in chronic fatigue syndrome.

Burbelo PD, Bayat A, Wagner J, Nutman TB, Baraniuk JN, Iadarola MJ.

Am J Transl Res. 2012;4(4):443-51. Epub 2012 Oct 10.

Supplemental Content

Support Center